A Study of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Conditions: Respiratory Syncytial Virus Interventions: Biological: mRNA-1345; Biological: Placebo Sponsors: ModernaTX, Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials